Xu, Y.; Robev, D.; Saha, N.; Wang, B.; Dalva, M.B.; Xu, K.; Himanen, J.P.; Nikolov, D.B.
The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism. Int. J. Mol. Sci. 2021, 22, 10473.
https://doi.org/10.3390/ijms221910473
AMA Style
Xu Y, Robev D, Saha N, Wang B, Dalva MB, Xu K, Himanen JP, Nikolov DB.
The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism. International Journal of Molecular Sciences. 2021; 22(19):10473.
https://doi.org/10.3390/ijms221910473
Chicago/Turabian Style
Xu, Yan, Dorothea Robev, Nayanendu Saha, Bingcheng Wang, Matthew B. Dalva, Kai Xu, Juha P. Himanen, and Dimitar B. Nikolov.
2021. "The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism" International Journal of Molecular Sciences 22, no. 19: 10473.
https://doi.org/10.3390/ijms221910473
APA Style
Xu, Y., Robev, D., Saha, N., Wang, B., Dalva, M. B., Xu, K., Himanen, J. P., & Nikolov, D. B.
(2021). The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism. International Journal of Molecular Sciences, 22(19), 10473.
https://doi.org/10.3390/ijms221910473